Luca Massacesi
Neurology — Careggi University Hospital, Italy
Luca Massacesi
LeadR Profile
Neurology
Subspecialties: Immunology - Public Health - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1988 - 2026
Number : 200
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Diagnosis and Management of Infectious Encephalitis in Adults: Guidelines From the European Academy of Neurology and European Society of Clinical Microbiology and Infectious Diseases. polymerase chain reaction, microbiology, diagnosis, therapeutics, nervous system diseases, infectious encephalitis, neurology, communicable diseases, encephalitis | Eur J Neurol | 2026 | 0 |
| Autologous haematopoietic stem cell transplantation affects paramagnetic rim lesions in multiple sclerosis. cells, sclerosis, multiple sclerosis, microscopy, electron, scanning transmission, central nervous system diseases, hematopoietic stem cell transplantation, magnetic resonance imaging, stem cells, biomarkers, central nervous system, demyelinating diseases, therapeutics, cell transplantation, nervous system, stem cell transplantation, wounds and injuries, transplantation | Mult Scler | 2026 | 0 |
| Stimulated single-fiber electromyography in the diagnostic workup of diplopia and ptosis. electromyography, diplopia, predictive value of tests, diagnosis | Clin Neurophysiol Pract | 2026 | 0 |
| Real-World Data for Safety Studies: Challenges and Opportunities From the Italian Multiple Sclerosis and Related Disorders Register. registries, sclerosis, multiple sclerosis, epidemiology, safety, drug utilization, drug-related side effects and adverse reactions, pharmacology, clinical, therapeutics, pharmacoepidemiology | Pharmacoepidemiol Drug Saf | 2026 | 0 |
| A multispecialty consensus-based red flag checklist for the early recognition of ANCA-associated vasculitis. vasculitis, early diagnosis, laboratories, ear, anti-neutrophil cytoplasmic antibody-associated vasculitis | Front Immunol | 2026 | 0 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 5
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Effect of siponimod on relevant imaging and immunological hallmarks of progressive multiple sclerosis 2024-518374-13-00 — sclerosis, multiple sclerosis | Phase 4 | Recruiting | 2022 |
LeadR Networks
Main global connection map